Literature DB >> 10641610

Neurologic presentations of mitochondrial disorders.

A Nissenkorn1, A Zeharia, D Lev, N Watemberg, A Fattal-Valevski, V Barash, A Gutman, S Harel, T Lerman-Sagie.   

Abstract

This article describes the neurologic presentations of children with mitochondrial disorders. The charts of 42 children with highly suspect mitochondrial disorders were reviewed. Thirty-seven children were diagnosed as having definite mitochondrial disorders based on a suggestive clinical presentation and at least one accepted criteria, while in five patients the diagnosis remained probable. All patients had nervous system involvement, but it was the presenting symptom in 28 of 42. Eighteen children had normal intelligence and 24 had mental retardation or developmental delay at the onset of their disease. Twenty-five patients had either an acute regression or a progressive encephalopathy. The most frequent neurologic manifestations were abnormal tone, seizures, extrapyramidal movements, and autonomic dysfunction. The eyes were involved in 11 children. Nerve deafness was found in seven patients. Myopathy was found in only six patients. In conclusion, a complex neurologic picture, especially with other organ involvement, warrants a full mitochondrial evaluation.

Entities:  

Mesh:

Year:  2000        PMID: 10641610     DOI: 10.1177/088307380001500110

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  17 in total

1.  Iron deficiency in children with mitochondrial disease.

Authors:  Hye Eun Kwon; Jung Hun Lee; Young Mock Lee; Hoon Chul Kang; Joon Soo Lee; Heung Dong Kim
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

Review 2.  Coenzyme Q10 a mitochondrial restorer for various brain disorders.

Authors:  Nilima Pradhan; Charan Singh; Arti Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-10-01       Impact factor: 3.195

3.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.

Authors:  Doris D M Lin; Thomas O Crawford; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

4.  Cognitive functioning and psychiatric disorders in children with a metabolic disease.

Authors:  Annik Simons; François Eyskens; Ann De Groof; Ellen Van Diest; Dirk Deboutte; Robert Vermeiren
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-03-10       Impact factor: 4.785

Review 5.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

Review 6.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

Review 7.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  D A Rossignol; R E Frye
Journal:  Mol Psychiatry       Date:  2011-01-25       Impact factor: 15.992

8.  Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.

Authors:  Jacqueline R Weissman; Richard I Kelley; Margaret L Bauman; Bruce H Cohen; Katherine F Murray; Rebecca L Mitchell; Rebecca L Kern; Marvin R Natowicz
Journal:  PLoS One       Date:  2008-11-26       Impact factor: 3.240

9.  Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke.

Authors:  Chaya G Bhuvaneswar; Jared L Goetz; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Brain region-specific altered expression and association of mitochondria-related genes in autism.

Authors:  Ayyappan Anitha; Kazuhiko Nakamura; Ismail Thanseem; Kazuo Yamada; Yoshimi Iwayama; Tomoko Toyota; Hideo Matsuzaki; Taishi Miyachi; Satoru Yamada; Masatsugu Tsujii; Kenji J Tsuchiya; Kaori Matsumoto; Yasuhide Iwata; Katsuaki Suzuki; Hironobu Ichikawa; Toshiro Sugiyama; Takeo Yoshikawa; Norio Mori
Journal:  Mol Autism       Date:  2012-11-01       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.